Privacy‑first governance for healthcare AI
A recent post from MediMint argues for privacy‑first data governance and tokenized diagnostics in healthcare AI, emphasising compliance and transparency as central to regulated innovation. The framing stresses that governance must be built to protect patient data while enabling useful models, not grafted on after the fact. (x.com)
Most healthcare artificial intelligence fails at the same boring step: getting patient data from one hospital system to another without turning privacy into an afterthought. MediMint’s pitch is that the data rules have to be built first, before the model ever touches a scan or record. (medimint.health) In U.S. healthcare, the Health Insurance Portability and Accountability Act privacy rule gives patients rights over protected health information, including the right to inspect records, get copies, and request corrections. Any company training or deploying medical artificial intelligence around those records has to fit inside that legal frame, not work around it. (hhs.gov) That sounds obvious until you look at how medical images still move. MediMint says its original problem was that patients often wait days for copies of magnetic resonance imaging scans on compact discs, even when treatment decisions depend on fast sharing. (medimint.health, gwu.edu) A privacy-first system treats data like a bank vault with a logbook on the door. The point is not just locking files up, but recording who opened them, when they opened them, and what permission they had at that moment. (hhs.gov, hhs.gov) That is why compliance keeps showing up in every serious healthcare artificial intelligence discussion. The International Association of Privacy Professionals wrote in 2025 that privacy counsel and compliance officers need to be involved early, with contracts spelling out data rights, model transparency, and accountability instead of trying to fix those questions at launch. (iapp.org) The “tokenized diagnostics” part of MediMint’s story is separate from the patient-record problem, but connected to the same trust problem. The company says it wants to represent diagnostic assets such as magnetic resonance imaging, computed tomography, and ultrasound machines on blockchain rails so ownership, revenue shares, or usage rights can be tracked more transparently. (medimint.io, iq.wiki) In plain English, tokenization is a digital receipt system. Instead of one spreadsheet in one office saying who owns a slice of a machine or who gets paid when it is used, the record sits on a shared ledger that multiple parties can inspect. (medimint.io, iq.wiki) That does not remove the hard part, which is regulation. If an artificial intelligence tool is making diagnostic claims, the U.S. Food and Drug Administration treats many of those products as medical devices, and the agency now maintains a public list of artificial intelligence-enabled devices already cleared or authorized for marketing. (fda.gov) The Food and Drug Administration has also spent the past two years pushing developers on transparency, bias, documentation, and good machine learning practice. In January 2025, the agency issued draft guidance for developers of artificial intelligence-enabled medical devices, and its broader guidance says transparency has to be considered across the product life cycle, not bolted on after release. (fda.gov, fda.gov, fda.gov) The federal privacy side is tightening too. On December 27, 2024, the Department of Health and Human Services proposed updates to the health security rule aimed at stronger cybersecurity requirements for health plans, providers, and clearinghouses after a run of major cyberattacks. (hhs.gov) So the real argument in MediMint’s post is not “use blockchain” or “use artificial intelligence.” It is that in healthcare, the winning products will be the ones that can show a regulator, a hospital, and a patient the same paper trail for privacy, consent, access, and model use from day one. (medimint.health, fda.gov, hhs.gov)
